GlassScriptPhysician profile
Justin Lee Glancy
NPI 1336868066
$987.80
in general payments reported to CMS, 2019-2025
8 companies · $790 in 2025
The $790 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $16.57 · 2024: $182 · 2025: $790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $958 · Education: $30.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $957.80 |
| Education | $30.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $439.51 | 2023-2025 | Ortholoc 3di, Augment Injectable, Prostep |
| Globus Medical, INC. | $290.19 | 2025 | Senza |
| Integra Lifesciences Corporation | $150.93 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $30.00 | 2024 | |
| Biowound Solutions, INC. | $22.44 | 2025 | Bio-Connekt |
| Curonix LLC | $20.19 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Solventum Corporation | $20.03 | 2024 | V.A.C. Veraflo, Prevena |
| Paratek Pharmaceuticals, INC. | $14.51 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Glancy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.